Nexentis Technologies Inc. (NXTS)
About Nexentis Technologies Inc.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $210.0K
- Net income
- -$4.0M
- Total assets
- $20.4M
- Market cap
- $4.2M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.2M
- Shares outstanding
- 2.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 15, 2009
Nexentis Technologies Inc. (NXTS) Stock Price
- Reported a net loss of $4.0M in FY2024.
- Trading 86% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Nexentis Technologies Inc..
Write a review
Nexentis Technologies Inc.: frequently asked questions
Is Nexentis Technologies Inc. an American company?
Nexentis Technologies Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Nexentis Technologies Inc. headquartered?
Nexentis Technologies Inc. is headquartered in New York, New York, United States.
Is Nexentis Technologies Inc. publicly traded?
Yes — Nexentis Technologies Inc. is a publicly traded company. Its stock trades under the ticker symbol NXTS on the NASDAQ.
What does Nexentis Technologies Inc. do?
Nexentis Technologies Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
